Trueblood Wealth Management’s American Express AXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.33M Sell
3,941
-6
-0.2% -$1.92K 0.47% 64
2026
Q1
$1.19M Sell
3,947
-233
-6% -$78.1K 0.47% 68
2025
Q4
$1.55M Buy
4,180
+104
+3% +$37.2K 0.6% 51
2025
Q3
$1.35M Buy
4,076
+65
+2% +$20.7K 0.53% 62
2025
Q2
$1.28M Buy
4,011
+117
+3% +$32.9K 0.54% 60
2025
Q1
$1.05M Buy
3,894
+527
+16% +$156K 0.49% 69
2024
Q4
$999K Buy
3,367
+333
+11% +$95.7K 0.49% 64
2024
Q3
$823K Buy
3,034
+445
+17% +$111K 0.41% 79
2024
Q2
$599K Buy
2,589
+517
+25% +$120K 0.34% 95
2024
Q1
$472K Buy
2,072
+158
+8% +$32.8K 0.27% 109
2023
Q4
$359K Buy
+1,914
New +$308K 0.22% 130

Other funds holding AXP

Trueblood Wealth Management's AXP Position: Q2 2026 in Review

Trueblood Wealth Management reduced its American Express (AXP) stake by 0.15% in Q2 2026, selling an estimated $1.92K and leaving 3,941 shares worth $1.33M. The position accounts for 0.47% of the portfolio, ranked #64.

Trueblood Wealth Management first reported a position in AXP in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.55M in Q4 2025. 2,992 funds tracked by Wall St. Rank hold AXP as of Q2 2026.

  • Trueblood Wealth Management held 3,941 shares of American Express worth $1.33M as of Q2 2026.
  • Trueblood Wealth Management sold 6 American Express shares in Q2 2026, an estimated $1.92K.
  • American Express made up 0.47% of Trueblood Wealth Management's portfolio in Q2 2026, its #64 holding.
  • Trueblood Wealth Management first reported a position in American Express in Q4 2023 and has held it in 11 quarters since.
  • Trueblood Wealth Management's American Express position peaked at $1.55M in Q4 2025.
  • 2,992 funds tracked by Wall St. Rank held American Express as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.